Merck KGaA foresees post-pandemic localization of biologics supply chains Governments want to build up a vaccine and biologics infrastructure locally to insulate themselves from the sorts of supply disruptions seen in the COVID-19 pandemic, according to Merck KGaA CEO Stefan Oschmann.
Global competition for scarce, in-demand materials has exposed downsides of global supply chains throughout the pandemic, from early competition for personal protective equipment and diagnostic reagents through to the current rows over cross-border trade in COVID-19 vaccines. The experience could shape the attitudes of governments to trade and the need for local infrastructure.
“I have, almost on a daily basis, heads of government, people from the EU commission, from various countries on the phone who tell us that one of the lessons out of this pandemic is that our healthcare systems must become more resilient and that they.. want to build up a vaccine and biologics in